U.S. stocks gaped down this morning after recent rally on Friday. However, there are several stocks which are showing solid gains:-
A123 Systems, Inc.(NASDAQ:AONE) shares are showing solid
recovery in the opening session on Friday with a gain of 21.40% to $0.839 on
hefty volume after the company reached with China's Ray Power Systems to supply
a 2MW grid energy storage system. Though 2MW may not sound like much, Ray Power
proclaims the deal will "validate the technical capabilities" of grid
storage, and A123 is hopeful it will open up new opportunities in China.
Selling energy tech in the country has its risks, as American Superconductor
and Maxwell can vouch.
Can AONE Bounce back
above $1 Mark? Find Free Trend
Analysis
Pluristem Therapeutics Inc.(NASDAQ:PSTI) extended its prior
session’s gain and rose 15.62% to $3.70 after creating a new 52-week high of
$3.85. Yesterday, the stock ended higher by 19% after the Israeli biotech
company announced that CPC Clinical Research will be managing the company's
upcoming Phase II clinical trial for its proprietary stem-cell therapy in the
treatment of peripheral artery disease. Pluristem said that CPC is a specialist
in conducting clinical trials for the condition.
How Should Investors
Trade PSTI after Recent Rally, Get Trend
Analysis
Merrimack Pharmaceuticals Inc(NASDAQ:MACK) added 9% to $7.89
and made a new 52-week high of $9.20 earlier in the session. Earlier this week,
the company announced the election of James Quigley, CEO emeritus of Deloitte
Touche Tohmatsu, Limited (the Deloitte Global Network), to its Board of
Directors. Merrimack is a biopharmaceutical company dedicated to the discovery
and development of novel medicines for the treatment of cancer.
Get Trend Analysis on
MACK
StemCells, Inc.(NASDAQ:STEM) added 13% to $1.58. Earlier
this week, the company announced preclinical data demonstrating that its
proprietary human neural stem cells restored memory and enhanced synaptic
function in two animal models relevant to Alzheimer's disease (AD). The data
was presented today at the Alzheimer's Association International Conference
2012 in Vancouver, Canada.
No comments:
Post a Comment